Skip to main content
Home
  • Home
  • Avemar Publications
  • Journals
  • Research centers
  • Avemar in cancer treatment
HU US-UK FR ES DE 中文

Mediterranean Journal of Nutrition and Metabolism

Nichelatti M, Sukkar SG, Cella F, et al. (2008): A multicentric prospective open trial on the quality of life and oxidative stress in patients affected by advanced head and neck cancer treated with a new benzoquinone-rich product derived from fermented wheat germ (Avemar). Mediterranean Journal of Nutrition and Metabolism.

Search form

  • Papers on Avemar
  • What is Avemar?
  • Avemar in cancer treatment
  • Scientific background
  • Mechanism of action
  • Safety profile

The information on this website is provided for informational purposes only and is not meant to diagnose or treat any health problem or disease or be a substitute for advice provided by a doctor or other qualified health care professional. Patients should always consult with a doctor or other health care professionals for medical advice or information about a diagnosis and/or treatment. In the case of diagnosis or treatment of any disease, particularly tumour related diseases, a health care professional should always be consulted. Do not attempt to self-treat.

Privacy policy

Avemar Design System by Gilanyi & Magos Professional Design.

Disclaimer


This site is intended for use by non-US citizens only.

If you are from the US, please visit this site.

If you are NOT from the US, please continue here.